Skip to main content
OpenTrials
Completed

NCT Number: NCT04583085

Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery Disease

The role of micro-RNAs in chronic periodontitis associated with CAD is still in an incipient stage needs to be explored further. The investigators attempt to quantify and compare the levels of micro-RNA 146a and micro-RNA 126 in subgingival as well as coronary plaque samples obtained from patients diagnosed with chronic periodontitis with and without coronary artery disease.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The role of micro-RNAs in chronic periodontitis associated with CAD is still in an incipient stage needs to be explored further. The investigators attempt to quantify and compare the levels of micro-RNA 146a and micro-RNA 126 in subgingival as well as coronary plaque samples obtained from patients diagnosed with chronic periodontitis with and without coronary artery disease.

Seventy-five participants were selected and grouped into 3 categories; 25 patients diagnosed with chronic periodontitis and coronary artery disease: CP + CAD group; 25 patients diagnosed with chronic periodontitis alone: CP group; and 25 systemically and periodontally healthy controls (HP). Demographic variables, periodontal parameters, cardiac parameters, blood pressure were obtained. miRNA-146a and miRNA126 levels were assessed in subgingival plaque (SP) samples from all the three groups. Within CP+CAD group, SP samples of CP+CADa were compared with coronary plaques samples (CP) of CP+CADb while the patient underwent CABG.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients volunteering for the investigation.
  • Patients between the age group of 30-70 years
  • Presence of ≥ 15 natural teeth.

Exclusion criteria

  • Patients associated with systemic diseases such as lung disorders, renal disease, liver disease, type I, type II-diabetes mellitus, HIV infection, rheumatoid arthritis, allergy or any malignancy.
  • Under treatment with antibiotics, immunosuppressive drugs such as corticosteroids, within 6 months.
  • Pregnant women and female patients were excluded because of the altered oral flora due to hormonal changes
  • Smoking and other tobacco usage habits
  • Patients who underwent periodontal treatment within 6 months.

Treatment and study plan

Primary outcomes

  1. micro-RNA 146-a expression in Chronic periodontitis patients with and without coronary heart disease.

    Time frame: 10 months

    microRNA 146-a expression was present in the chronic periodontitis subjects with coronary heart disease

  2. Levels of micro-RNA 126 in chronic periodontitis patients with and without coronary heart disease

    Time frame: 10 months

    microRNA 126 expression was present in chronic periodontitis subjects with coronary heart disease

Sponsors and collaborators

Lead sponsor

Meenakshi Ammal Dental College and Hospital

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Oct 12, 2020
Registry last updated
Oct 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.